Standout Papers

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study 2022 2026 2023 2024103
  1. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study (2022)
    Joanne Wildenbeest, Marie‐Noëlle Billard et al. The Lancet Respiratory Medicine

Immediate Impact

34 standout
Sub-graph 1 of 11

Citing Papers

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
4 intermediate papers

Works of Koos Korsten being referenced

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
2022 Standout
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Koos Korsten 295 134 65 133 13 319
Ann Bett 308 122 96 75 10 340
Faye J. Lim 248 92 64 52 17 318
Frederic Reicherz 232 123 96 37 13 276
Mireia Alcazar‐Paris 180 266 28 166 15 341
Cristina García-Mauriño 249 158 76 87 15 340
Fathima Naby 234 95 71 45 11 274
N. Wynn-Williams 149 116 180 158 20 361
Frederic W. Bruhn 233 113 76 57 8 334
Linny Kimly Phuong 160 70 101 91 19 280
Sarah Harney 285 50 39 121 10 359

All Works

Loading papers...

Rankless by CCL
2026